Study to Evaluate the Efficacy of Oral Dissolving Metoclopramide Before Video Capsule Endoscopy
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Summary:
This study investigates the use of oral dissolving metoclopramide during standard video
capsule endoscopy. Metoclopramide is a pro -motility agent, that is, this medication helps
with movement through the stomach and small bowel. This study will help us determine the
effectiveness of oral dissolving metoclopramide on transit time through the stomach and small
bowel of the video capsule that is ingested. This study may help with better diagnoses of
pathology in the small bowel. Each patient enrolled in the study will either be assigned to a
group that only ingests the capsule or the group that receives the oral dissolving
metoclopramide plus capsule. Each patient will undergo the same standard procedures and
precaution used during standard video capsule endoscopy. The patients that will qualify for
the study are patients that are in need of video capsule endoscopy for further imaging of the
small bowel. The patients must meet the inclusion criteria provided in the protocol and must
not meet any of the exclusion criteria in the protocol. The hypothesis is that the patients
that ingest the metoclopramide will have better capsule images and transit time and will
allow for enhanced diagnosis of small bowel pathology.